Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $275.0000 (-1.79%) ($255.0000 - $297.5000) on Wed. Oct. 12, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.71% (three month average) | RSI | 22 | Latest Price | $275.0000(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(4%) PEJ(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -2.355% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.355% (StdDev 4.71%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $309.74 | 5 Day Moving Average | $296(-7.09%) | 10 Day Moving Average | $303.74(-9.46%) | 20 Day Moving Average | $309.74(-11.22%) | To recent high | -30.4% | To recent low | 0% | Market Cap | $5.417b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |